Aeshna vercanica sp. nov. from Iran with a new insight into the Aeshna cyanea-group (Odonata: Aeshnidae)

Aeshna vercanica sp. nov. is described and illustrated. The male holotype and four male paratypes were collected on 15-vii-2013 in the Hyrcanian forest of the Alborz Mountains, Mazandaran province, northwestern Iran. A specimen collected on 29-vi-2002 in the Talysh Hills, Lankoran area, Azerbaijan, also belongs to the new species. In July 2014 the species, including females, was recorded again at the type locality and additionally ca 400 km further east in Golestan province. Males are similar to Aeshna cyanea in the structure of genitalia and terminalia but differ in head morphology, pterostigma length, colour pattern, and behaviour. Females have small abdominal blue or turquoise postero-median dorsal spots which are absent on S9 and S10, thin green antehumeral stripes, a less robust appearance than females of A. cyanea, and are more slender and longer. The range of A. vercanica sp. nov. covers the Hyrcanian forest along the southern margin of the Caspian Sea. Analysis of the barcoding COI sequence of DNA confirmed that A. vercanica sp. nov. is separated from A. cyanea by a genetic distance of ca 4%. The ITS gave a similar result. A haplotype map could not derive A. vercanica sp. nov. directly from A. cyanea. They are thus related but different species, and we suggest the common ancestor lived in pre-Pleistocene times. Analysis of A. cyanea specimens from across its range also revealed a western clade from the Maghreb to Central Europe. Populations from the Caucasus to Eastern Europe were polytomous, a common scenario for post-glacial invaders. A molecular comparison of the species pair A. juncea and A. subarctica showed these to be even more closely related than A. cyanea and A. vercanica sp. nov

Fast Algorithms and Efficient Statistics: N-point Correlation Functions

We present here a new algorithm for the fast computation of N-point correlation functions in large astronomical data sets. The algorithm is based on kdtrees which are decorated with cached sufficient statistics thus allowing for orders of magnitude speed-ups over the naive non-tree-based implementation of correlation functions. We further discuss the use of controlled approximations within the computation which allows for further acceleration. In summary, our algorithm now makes it possible to compute exact, all-pairs, measurements of the 2, 3 and 4-point correlation functions for cosmological data sets like the Sloan Digital Sky Survey (SDSS; York et al. 2000) and the next generation of Cosmic Microwave Background experiments (see Szapudi et al. 2000).Comment: To appear in Proceedings of MPA/MPE/ESO Conference "Mining the Sky", July 31 - August 4, 2000, Garching, German

The UCSC Archaeal Genome Browser

As more archaeal genomes are sequenced, effective research and analysis tools are needed to integrate the diverse information available for any given locus. The feature-rich UCSC Genome Browser, created originally to annotate the human genome, can be applied to any sequenced organism. We have created a UCSC Archaeal Genome Browser, available at , currently with 26 archaeal genomes. It displays G/C content, gene and operon annotation from multiple sources, sequence motifs (promoters and Shine-Dalgarno), microarray data, multi-genome alignments and protein conservation across phylogenetic and habitat categories. We encourage submission of new experimental and bioinformatic analysis from contributors. The purpose of this tool is to aid biological discovery and facilitate greater collaboration within the archaeal research community

Instruments for reproducible setting of defects in cartilage and harvesting of osteochondral plugs for standardisation of preclinical tests for articular cartilage regeneration

Background: Standardisation is required in research, so are approval procedures for advanced therapy medical products and other procedures for articular cartilage therapies. The process of creating samples needs to be reproducible. The aim of this study was to design, create and validate instruments (1) to create reproducible and accurate defects and (2) to isolate samples in the shape of osteochondral cylinders in a quick, reliable and sterile manner. Methods: Adjustable instruments were created: a crown mill with a resolution of 0.05 mm and a front mill to create defects in articular cartilage and subchondral bone. The instruments were tested on knee joints of pigs from the slaughterhouse; 48 defects were created and evaluated. A punching machine was designed to harvest osteochondral plugs. These were validated in an in vivo animal study. Results: The instruments respect the desired depth of 0.5 and 1.5 mm when creating the defects, depending on whether the person using the instrument is highly experienced (0.451 mm; confidence interval (CI): 0.390 mm; 0.512 mm and 1.403 mm; CI: 1.305 mm; 1.502 mm) or less so (0.369 mm; CI: 0.297 mm; 0.440 mm and 1.241 mm; CI: 1.141 mm; 1.341 mm). Eighty samples were taken from knee joints of Göttingen Minipigs with this punching technique. The time needed for the harvesting of the samples was 7.52 min (±2.18 min), the parallelism of the sides of the cylinders deviated by −0.63° (CI: −1.33°; 0.08°) and the surface of the cartilage deviated from the perpendicularity by 4.86° (CI: 4.154°; 5.573°). In all assessed cases, a sterile procedure was observed. Conclusions: Instruments and procedures for standardised creation and validation of defects in articular cartilage and subchondral bone were designed. Harvesting of samples in the shape of osteochondral cylinders can now be performed in a quick, reliable and sterile manner. The presented instruments and procedures can serve as helpful steps towards standardised operating procedures in the field of regenerative therapies of articular cartilage in research and for regulatory requirements

Probing magnetic properties at the nanoscale: in-situ Hall measurements in a TEM

We report on advanced in-situ magneto-transport measurements in a transmission electron microscope. The approach allows for concurrent magnetic imaging and high resolution structural and chemical characterization of the same sample. Proof-of-principle in-situ Hall measurements on presumably undemanding nickel thin films supported by micromagnetic simulations reveal that in samples with non-trivial structures and/or compositions, detailed knowledge of the latter is indispensable for a thorough understanding and reliable interpretation of the magneto-transport data. The proposed in-situ approach is thus expected to contribute to a better understanding of the Hall signatures in more complex magnetic textures

Genome sequence data of Bacillus velezensis BP1.2A and BT2.4

Here, we report the complete genome sequence data of the biocontrol strains Bacillus velezensis BP1.2A and BT2.4 isolated from Vietnamese crop plants. The size of the genomes is 3,916,868 bp (BP1.2A), and 3,922,686 bp (BT2.4), respectively. The BioProjects have been deposited at NCBI GenBank. The GenBank accession numbers for the B. velezensis strains are PRJNA634914 (BP1.2A) and PRJNA634832 (BT2.4) for the BioProjects, CP085504 (BP1.2A) and CP085505 (BT2.4) for the chromosomes, GCA_013284785.2 (BP2.1A), and GCA_013284785.2 (BT2.4) for GenBank assembly accessions, and SAMN15012571 (BP1.2A) and SAMN15009897 (BT2.4) for the BioSamples. Both genomes were closely related to FZB42, the model strain for plant growth promoting bacilli.Peer Reviewe

Accountability in Medicaid Managed Care: Implications for Pediatric Health Care Quality

This study examines the structure and operation of Medicaid and State Children\u27s Health Insurance Program (SCHIP) health care access and quality monitoring systems for children enrolled in comprehensive managed care arrangements. As the single largest purchasers of pediatric health care in the U.S., Medicaid and SCHIP agencies play a potentially powerful role in pediatric health policy. How these agencies approach, design, and carry out health quality monitoring activities has the potential to have a major impact not only for poor and low-income children, but for the entire pediatric health system. Even when these systems are developed exclusively for publicly insured children, their influence can extend beyond the four corners of a specific contractual arrangement, since participating health professionals, health care institutions and businesses typically are not exclusive to these arrangements, and the devolutionary influence of one purchaser\u27s expectations thus can travel beyond the scope of the agreement

Draft Genome Sequence of Burkholderia puraquae Type Strain CAMPA 1040, Isolated from Hospital Settings in Córdoba, Argentina

We report here the draft genome sequence of Burkholderia puraquae type strain CAMPA 1040, a member of the Burkholderia cepacia complex. This strain, isolated from a hemodialysis water reservoir, harbors several stress tolerance genes, such as the systems for low oxygen survival, for copper tolerance, and for osmotic stress resistance.Facultad de Ciencias Exacta

Gangliosides: Treatment Avenues in Neurodegenerative Disease

Gangliosides are cell membrane components, most abundantly in the central nervous system (CNS) where they exert among others neuro-protective and -restorative functions. Clinical development of ganglioside replacement therapy for several neurodegenerative diseases was impeded by the BSE crisis in Europe during the 1990s. Nowadays, gangliosides are produced bovine-free and new pre-clinical and clinical data justify a reevaluation of their therapeutic potential in neurodegenerative diseases. Clinical experience is greatest with monosialo-tetrahexosyl-ganglioside (GM1) in the treatment of stroke. Fourteen randomized controlled trials (RCTs) in overall >2,000 patients revealed no difference in survival, but consistently superior neurological outcomes vs. placebo. GM1 was shown to attenuate ischemic neuronal injuries in diabetes patients by suppression of ERK1/2 phosphorylation and reduction of stress to the endoplasmic reticulum. There is level-I evidence from 5 RCTs of a significantly faster recovery with GM1 vs. placebo in patients with acute and chronic spinal cord injury (SCI), disturbance of consciousness after subarachnoid hemorrhage, or craniocerebral injuries due to closed head trauma. In Parkinson's disease (PD), two RCTs provided evidence of GM1 to be superior to placebo in improving motor symptoms and long-term to result in a slower than expected symptom progression, suggesting disease-modifying potential. In Alzheimer's disease (AD), the role of gangliosides has been controversial, with some studies suggesting a "seeding" role for GM1 in amyloid β polymerization into toxic forms, and others more recently suggesting a rather protective role in vivo. In Huntington's disease (HD), no clinical trials have been conducted yet. However, low GM1 levels observed in HD cells were shown to increase cell susceptibility to apoptosis. Accordingly, treatment with GM1 increased survival of HD cells in vitro and consistently ameliorated pathological phenotypes in several murine HD models, with effects seen at molecular, cellular, and behavioral level. Given that in none of the clinical trials using GM1 any clinically relevant safety issues have occurred to date, current data supports expanding GM1 clinical research, particularly to conditions with high, unmet medical need